6AYB | Oxidoreductase | date | Sep 08, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Naegleria Fowleri Cyp51-Ketoconazole Complex | ||||||||||||||
authors | A.Debnath, C.M.Calvet, G.Jennings, W.Zhou, A.Aksenov, M.Luth, R.Ab W.D.Nes, J.H.Mckerrow, L.M.Podust | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Cyp51, Sterol 14alpha-Demethylase Chain: A Engineered: Yes Other_details: Cys 371 And Cys 392 Are Spontaneously Oxidiz Sulfenic Acid Cso |
Organism_scientific: Naegleria Fowleri Organism_taxid: 5763 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_plasmid: Pcw-Lic | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.87 Å | ||||||||||||
ligand | CA, CSO, EDO, HEM, KKK | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)., Debnath A, Calvet CM, Jennings G, Zhou W, Aksenov A, Luth MR, Abagyan R, Nes WD, McKerrow JH, Podust LM, PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006104. doi:, 10.1371/journal.pntd.0006104. eCollection 2017 Dec. PMID:29284029 |
Data retrieval |
View 6AYB in 3D |
Visual 3D analysis of 6AYB |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6AYB |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |